By contrast, human tissues such as liver, stomach, kidney and endometrium that physiologically have high inhibitor protein levels, do not increase the IF1 content during cancer development (Sánchez-Aragó et al., 2013; Esparza-Moltó et al., 2017). The gene discussed is ATP5IF1; the disease is cancer.